Blood test predicts chance of dementia

Mar 06, 2009

VIB (the Flanders Institute for Biotechnology, Belgium) researchers connected to the Born-Bunge Institute and the University of Antwerp discovered the amount of growth factor progranulin in blood is a predictor of Frontotemporal Dementia (FTD). Progranulin plays a major role in the survival of brain cells. People producing less progranulin have higher risk of contracting FTD. The researchers developed a test, measuring the amount of progranulin in the blood thus predicting a person's risk. This offers possibilities for early detection.

Frontal lobe dementia (Frontotemporal Dementia, FTD) strikes people at an earlier age. After Alzheimer's disease, FTD is the form of dementia that occurs most frequently in patients younger than 65. In FTD, the disease process starts in the frontal lobe where large numbers of brain cells begin to die off. The frontal lobe is the foremost part of the brain and constitutes about 30% of the brain. Among other things, it is involved in regulating behavior, movement and mood, and it is responsible for cognitive functions such as language. So, the first clinical signs of FTD are changes in behavior and personality, and then, in a later stage of the disease, the loss of memory functions.

Progranulin: a main actor

Genetic research has shown previously that there is a genetic defect in chromosome 17 in a large percentage of the families with FTD. There are two genes in chromosome 17 that, if a defect occurs, cause a hereditable form of FTD. In 1998, defects were found in the gene for the tau protein, a substance that appears in the protein clots in the brains of FTD and Alzheimer's patients. In 2006, Christine Van Broeckhoven's team discovered hereditable defects in the gene for the progranulin protein. They predicted that people with these hereditable defects produce only half of the normal amount of progranulin.

This has been confirmed by Christine Van Broeckhoven's team, who have shown that a shortage of this growth factor leads to the dying off of brain cells in the frontal lobe and in this way causes FTD. New results indicate that progranulin also plays a role in the death of brain cells in other diseases of the brain, such as Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS).

On the basis of their research, Kristel Sleegers, a scientist in Van Broeckhoven's team, has developed a test for measuring the quantity of progranulin in the blood in a simple way. This test enables one to determine whether someone has an increased risk of FTD due to a shortage of progranulin long before symptoms appear. The blood test can be used on a large scale and is much more simple and user-friendly than the current genetic tests. This finding also offers prospects for the early detection of FTD caused by a shortage of progranulin.

However, it is still too early for a medicine to combat FTD. Further scientific research is needed to determine how a shortage of progranulin can be restored to normal.

Source: VIB (the Flanders Institute for Biotechnology)

Explore further: Second bird flu case confirmed in Canada

add to favorites email to friend print save as pdf

Related Stories

Autistic mice act a lot like human patients

Sep 29, 2011

UCLA scientists have created a mouse model for autism that opens a window into the biological mechanisms that underlie the disease and offers a promising way to test new treatment approaches.

Sediba hominid skull hints at later brain evolution

Sep 08, 2011

An analysis of a skull from the most complete early hominid fossils ever found suggests that the large and complex human brain may have evolved more rapidly than previously realized, and at a later time than some other human ...

Striking the right chords

Mar 30, 2011

Practice was nearly over when high school wrestler Darrin Ching collapsed and found himself pinned to the mat, a searing pain gripping his right temple. Alarmed, his coach and teammates huddled around and tried to get him ...

Scientists describe new model for neurodegeneration

Mar 10, 2011

A team of scientists at the University of California, San Francisco (UCSF) has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease. ...

Recommended for you

Second bird flu case confirmed in Canada

2 hours ago

The husband of a Canadian who was diagnosed earlier this week with bird flu after returning from a trip to China has also tested positive for the virus, health officials said Friday.

What exactly is coronavirus?

8 hours ago

The conflicts in Syria and Iraq are straining public health systems and public health efforts meant to prevent and detect the spread of infectious diseases. This is generating a "perfect storm" of conditions for outbreaks. Among the infections raising concern is Middle East Respiratory Syndrome, caused by a type of coronavirus, which emerged in 2012. ...

Scientists find Ebola virus is mutating

9 hours ago

(Medical Xpress)—Researchers working at Institut Pasteur in France have found that the Ebola virus is mutating "a lot" causing concern in the African countries where the virus has killed over eight thous ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.